Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BLRX

Bioline Rx Ltd ADR

May 14 • 04:00PM ET

3.06

-0.07 -2.24 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: IMNN AVTX TNXP PALI BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.18	Insider Own	0.56%	Shs Outstand	4.35M	Perf Week	-1.29%
Market Cap	13.31M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	0.00%	Shs Float	4.33M	Perf Month	28.57%
Enterprise Value	7.73M	PEG	-	EPS next Q	-1.04	Inst Own	1.04%	Short Float	3.64%	Perf Quarter	4.79%
Income	-1.30M	P/S	11.19	EPS this Y	-	Inst Trans	11.66%	Short Ratio	8.48	Perf Half Y	-8.38%
Sales	1.19M	P/B	0.73	EPS next Y	39.09%	ROA	-3.25%	Short Interest	0.16M	Perf YTD	10.47%
Book/sh	4.18	P/C	0.64	EPS next 5Y	-	ROE	-8.19%	52W High	7.77 -60.62%	Perf Year	-0.97%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	75.30% 66.78%	ROIC	-5.49%	52W Low	2.15 42.33%	Perf 3Y	-94.97%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	36.15%	Volatility	5.10% 7.73%	Perf 5Y	-97.32%
Dividend TTM	-	EV/Sales	6.50	EPS Y/Y TTM	96.05%	Oper. Margin	-871.39%	ATR (14)	0.21	Perf 10Y	-99.45%
Dividend Ex-Date	-	Quick Ratio	1.78	Sales Y/Y TTM	-95.92%	Profit Margin	-109.15%	RSI (14)	59.17	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.95	EPS Q/Q	78.83%	SMA20	10.60%	Beta	1.44	Target Price	17.50
Payout	-	Debt/Eq	0.56	Sales Q/Q	-98.35%	SMA50	18.69%	Rel Volume	0.68	Prev Close	3.13
Employees	24	LT Debt/Eq	0.30	Earnings	Mar 23 BMO	SMA200	-4.28%	Avg Volume	18.57K	Price	3.06
IPO	Jul 25, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.87% -62.26%	Trades		Volume	12,701	Change	-2.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)